![Matthew Foy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Foy
Direttore/Membro del Consiglio presso
Pulmocide Ltd.
Profilo
Mr. Matthew Foy is an Investor at Asceneuron SA and a Partner at GSK Equity Investments Ltd. He is on the Board of Directors at Akamis Bio Ltd., Fore Biotherapeutics, Inc. and Pulmocide Ltd. Mr. Foy was previously employed as an Independent Director by Decibel Therapeutics, Inc., an Operating Partner by SR One Capital Management LP, a Vice President by Greenhill & Co., Inc., and a Consultant by Longbow Capital Partners LP.
He also served on the board at Progenitor Labs Ltd., Atox Bio Ltd. and Puridify Ltd. He received his undergraduate degree from the University of Oxford, an undergraduate degree from St Peters College Oxford, a graduate degree from the University of Oxford and a graduate degree from St Peters College Oxford.
Posizioni attive di Matthew Foy
| Società | Posizione | Inizio |
|---|---|---|
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Investitore di Private Equity | 01/01/2011 |
Akamis Bio Ltd.
 Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies | Direttore/Membro del Consiglio | - |
Pulmocide Ltd.
 Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops inhaled medicines for viral and fungal infections of the respiratory diseases | Direttore/Membro del Consiglio | - |
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that specializes in cancer therapies | Direttore/Membro del Consiglio | - |
Asceneuron SA
 Asceneuron SA BiotechnologyHealth Technology Develops therapeutics for neurodegenerative disorders | Investitore di Private Equity | 01/09/2015 |
Precedenti posizioni note di Matthew Foy
| Società | Posizione | Fine |
|---|---|---|
Progenitor Labs Ltd.
 Progenitor Labs Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs to regenerate specific tissues of the human body in response to injury, disease, and ageing | Direttore/Membro del Consiglio | 25/07/2018 |
Puridify Ltd.
 Puridify Ltd. Miscellaneous Commercial ServicesCommercial Services Develops bioprocessing technologies | Direttore/Membro del Consiglio | 24/11/2017 |
| GREENHILL & CO., INC. | Corporate Officer/Principal | 01/01/2010 |
SR One Capital Management LP
 SR One Capital Management LP Investment ManagersFinance SR One invests in companies located in the United States and the United kingdom. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Investitore di Private Equity | - |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Formazione di Matthew Foy
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
84
Relazioni di 1° grado
14
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Greenhill & Co., Inc.
 Greenhill & Co., Inc. Investment Banks/BrokersFinance Operates as an investment bank that provides financial advisory services | Finance |
Longbow Capital Partners LP
 Longbow Capital Partners LP Investment ManagersFinance Longbow is a long/short investment firm focused on investing primarily in the equity securities of companies within the utility, power, energy midstream and related infrastructure sectors. The firm seeks superior risk-adjusted, investment returns with low correlation to the equity market. | Finance |
Atox Bio Ltd.
 Atox Bio Ltd. BiotechnologyHealth Technology Provides novel immune modulators for critically ill patients with severe infections | Health Technology |
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies | Health Technology |
St Peters College Oxford
 St Peters College Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Progenitor Labs Ltd.
Progenitor Labs Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs to regenerate specific tissues of the human body in response to injury, disease, and ageing | Health Technology |
Asceneuron SA
Asceneuron SA BiotechnologyHealth Technology Develops therapeutics for neurodegenerative disorders | Health Technology |
Pulmocide Ltd.
Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops inhaled medicines for viral and fungal infections of the respiratory diseases | Health Technology |
Puridify Ltd.
Puridify Ltd. Miscellaneous Commercial ServicesCommercial Services Develops bioprocessing technologies | Commercial Services |
Decibel Therapeutics, Inc.
 Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that specializes in cancer therapies | Health Technology |
SR One Capital Management LP
SR One Capital Management LP Investment ManagersFinance SR One invests in companies located in the United States and the United kingdom. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Finance |
